Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection
Clinical trial NCT04343755 · TERMINATED
Trial details
- NCT number
- NCT04343755
- Sponsor
- Hackensack Meridian Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-09
- Primary completion
- 2023-04-26
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.